Barbara Ann Dworetzky, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seizures | 41 | 2024 | 2998 | 4.450 |
Why?
|
Psychophysiologic Disorders | 14 | 2021 | 223 | 3.980 |
Why?
|
Epilepsy | 48 | 2024 | 3327 | 3.630 |
Why?
|
Conversion Disorder | 14 | 2023 | 203 | 2.930 |
Why?
|
Somatoform Disorders | 8 | 2019 | 425 | 2.560 |
Why?
|
Electroencephalography | 45 | 2024 | 6314 | 1.800 |
Why?
|
Anticonvulsants | 21 | 2017 | 1923 | 1.110 |
Why?
|
Death, Sudden | 8 | 2022 | 301 | 0.940 |
Why?
|
Epilepsies, Partial | 8 | 2016 | 435 | 0.840 |
Why?
|
Status Epilepticus | 8 | 2016 | 463 | 0.810 |
Why?
|
Monitoring, Physiologic | 7 | 2015 | 1798 | 0.740 |
Why?
|
Psychotherapy | 6 | 2019 | 1654 | 0.690 |
Why?
|
Sleep Apnea, Central | 2 | 2018 | 88 | 0.690 |
Why?
|
Nervous System Diseases | 5 | 2024 | 1662 | 0.620 |
Why?
|
Epilepsy, Generalized | 3 | 2015 | 181 | 0.520 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.510 |
Why?
|
Aphasia | 3 | 2013 | 193 | 0.510 |
Why?
|
Implantable Neurostimulators | 1 | 2016 | 75 | 0.490 |
Why?
|
Neurology | 3 | 2023 | 786 | 0.490 |
Why?
|
Prone Position | 2 | 2021 | 203 | 0.480 |
Why?
|
Dissociative Disorders | 2 | 2021 | 235 | 0.480 |
Why?
|
Heart Arrest | 4 | 2020 | 1516 | 0.480 |
Why?
|
Patient Compliance | 3 | 2019 | 2697 | 0.470 |
Why?
|
Psychopathology | 1 | 2017 | 434 | 0.460 |
Why?
|
Epilepsy, Complex Partial | 2 | 2011 | 59 | 0.460 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2013 | 390 | 0.410 |
Why?
|
Vagus Nerve Stimulation | 1 | 2016 | 228 | 0.400 |
Why?
|
Personality | 1 | 2015 | 559 | 0.390 |
Why?
|
Malformations of Cortical Development | 1 | 2013 | 176 | 0.380 |
Why?
|
Videotape Recording | 2 | 2010 | 335 | 0.370 |
Why?
|
Brain Waves | 4 | 2018 | 417 | 0.370 |
Why?
|
Adult | 66 | 2024 | 223646 | 0.360 |
Why?
|
Triazines | 6 | 2017 | 311 | 0.360 |
Why?
|
Premenstrual Syndrome | 1 | 2011 | 111 | 0.350 |
Why?
|
Cerebral Hemorrhage | 3 | 2018 | 2655 | 0.350 |
Why?
|
Magnetoencephalography | 6 | 2013 | 641 | 0.350 |
Why?
|
Women | 1 | 2011 | 225 | 0.340 |
Why?
|
Arrhythmias, Cardiac | 2 | 2010 | 2258 | 0.330 |
Why?
|
Autonomic Nervous System | 1 | 2015 | 707 | 0.330 |
Why?
|
Tachycardia | 4 | 2014 | 599 | 0.330 |
Why?
|
Contraceptives, Oral | 1 | 2011 | 560 | 0.320 |
Why?
|
Radiotherapy | 1 | 2016 | 1502 | 0.320 |
Why?
|
Interprofessional Relations | 1 | 2015 | 997 | 0.310 |
Why?
|
Menarche | 1 | 2011 | 538 | 0.310 |
Why?
|
Emergencies | 1 | 2015 | 1221 | 0.300 |
Why?
|
Middle Aged | 60 | 2024 | 223492 | 0.300 |
Why?
|
Emotions | 2 | 2019 | 2767 | 0.300 |
Why?
|
Humans | 107 | 2024 | 768166 | 0.290 |
Why?
|
Female | 72 | 2024 | 397192 | 0.290 |
Why?
|
Brain | 15 | 2022 | 27360 | 0.270 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2024 | 6029 | 0.250 |
Why?
|
Prospective Studies | 19 | 2024 | 54926 | 0.250 |
Why?
|
Male | 65 | 2024 | 364719 | 0.250 |
Why?
|
Sleep | 2 | 2018 | 4819 | 0.240 |
Why?
|
Young Adult | 25 | 2024 | 60066 | 0.240 |
Why?
|
Consciousness Disorders | 1 | 2010 | 445 | 0.240 |
Why?
|
Caffeine | 1 | 2009 | 703 | 0.240 |
Why?
|
Brain Neoplasms | 3 | 2016 | 9118 | 0.240 |
Why?
|
Cerebral Cortex | 4 | 2016 | 5812 | 0.230 |
Why?
|
Paranoid Disorders | 1 | 2024 | 61 | 0.230 |
Why?
|
Heart Rate | 2 | 2015 | 4214 | 0.220 |
Why?
|
Insurance, Health | 1 | 2016 | 2517 | 0.220 |
Why?
|
Patient Care Team | 1 | 2015 | 2523 | 0.220 |
Why?
|
Menstrual Cycle | 3 | 2012 | 546 | 0.210 |
Why?
|
Movement Disorders | 2 | 2019 | 463 | 0.210 |
Why?
|
Emergency Service, Hospital | 4 | 2019 | 7951 | 0.210 |
Why?
|
Primary Dysautonomias | 1 | 2022 | 28 | 0.210 |
Why?
|
Awareness | 2 | 2019 | 654 | 0.210 |
Why?
|
Anxiety | 4 | 2024 | 4672 | 0.200 |
Why?
|
Quality of Life | 6 | 2019 | 13490 | 0.200 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 13014 | 0.200 |
Why?
|
Acetamides | 2 | 2016 | 259 | 0.190 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2023 | 217 | 0.190 |
Why?
|
Monitoring, Ambulatory | 2 | 2017 | 358 | 0.190 |
Why?
|
Video Recording | 3 | 2012 | 976 | 0.180 |
Why?
|
Treatment Outcome | 18 | 2021 | 65371 | 0.180 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2593 | 0.180 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3415 | 0.180 |
Why?
|
Occupational Therapy | 1 | 2022 | 141 | 0.170 |
Why?
|
Comorbidity | 5 | 2024 | 10590 | 0.170 |
Why?
|
Pacemaker, Artificial | 3 | 2018 | 828 | 0.160 |
Why?
|
Therapeutic Equivalency | 2 | 2017 | 134 | 0.160 |
Why?
|
Cognition Disorders | 1 | 2013 | 3980 | 0.160 |
Why?
|
Progesterone | 3 | 2012 | 752 | 0.160 |
Why?
|
Mental Disorders | 7 | 2024 | 6874 | 0.160 |
Why?
|
Valproic Acid | 3 | 2016 | 444 | 0.150 |
Why?
|
Aged | 29 | 2024 | 171504 | 0.150 |
Why?
|
Retrospective Studies | 18 | 2023 | 81762 | 0.140 |
Why?
|
Analysis of Variance | 5 | 2017 | 6229 | 0.140 |
Why?
|
Alcohol Drinking | 1 | 2009 | 4045 | 0.130 |
Why?
|
General Adaptation Syndrome | 1 | 2016 | 7 | 0.130 |
Why?
|
Mass Media | 1 | 2019 | 303 | 0.130 |
Why?
|
Depersonalization | 1 | 2016 | 40 | 0.130 |
Why?
|
Nerve Net | 3 | 2014 | 2352 | 0.130 |
Why?
|
Personality Tests | 1 | 2015 | 80 | 0.130 |
Why?
|
Semantics | 3 | 1991 | 618 | 0.130 |
Why?
|
Piracetam | 1 | 2016 | 88 | 0.130 |
Why?
|
Clonazepam | 1 | 2015 | 135 | 0.120 |
Why?
|
Single-Blind Method | 1 | 2019 | 1587 | 0.120 |
Why?
|
Medical Records | 2 | 2011 | 1410 | 0.120 |
Why?
|
Parasomnias | 1 | 2014 | 27 | 0.120 |
Why?
|
Deep Brain Stimulation | 1 | 2023 | 851 | 0.120 |
Why?
|
Health Services | 1 | 2000 | 755 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 754 | 0.120 |
Why?
|
Lorazepam | 1 | 2015 | 155 | 0.120 |
Why?
|
Aged, 80 and over | 15 | 2019 | 59629 | 0.120 |
Why?
|
Psychometrics | 1 | 2024 | 3063 | 0.110 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2010 | 364 | 0.110 |
Why?
|
Drugs, Generic | 2 | 2017 | 455 | 0.110 |
Why?
|
Artifacts | 3 | 2011 | 1926 | 0.110 |
Why?
|
Periodicity | 1 | 2015 | 348 | 0.110 |
Why?
|
Follicular Phase | 2 | 2011 | 143 | 0.110 |
Why?
|
Luteal Phase | 2 | 2011 | 138 | 0.110 |
Why?
|
Adolescent | 20 | 2019 | 89169 | 0.110 |
Why?
|
Midazolam | 1 | 2015 | 267 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 2 | 2013 | 1567 | 0.110 |
Why?
|
Trail Making Test | 1 | 2013 | 57 | 0.110 |
Why?
|
Galvanic Skin Response | 1 | 2015 | 359 | 0.110 |
Why?
|
Drug Substitution | 1 | 2016 | 291 | 0.110 |
Why?
|
Coma | 1 | 2016 | 485 | 0.100 |
Why?
|
Hospital Units | 1 | 2013 | 142 | 0.100 |
Why?
|
Smoking | 1 | 2009 | 9092 | 0.100 |
Why?
|
Health Status | 2 | 2009 | 4091 | 0.100 |
Why?
|
Temporal Lobe | 2 | 2010 | 1726 | 0.100 |
Why?
|
Depression | 3 | 2024 | 8230 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2257 | 0.100 |
Why?
|
Narcolepsy | 1 | 2014 | 200 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39348 | 0.100 |
Why?
|
Veterans | 1 | 2005 | 2669 | 0.090 |
Why?
|
Functional Laterality | 3 | 2015 | 2264 | 0.090 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 412 | 0.090 |
Why?
|
Polysomnography | 2 | 2016 | 1871 | 0.090 |
Why?
|
Memory | 1 | 2001 | 2208 | 0.090 |
Why?
|
Mood Disorders | 1 | 2017 | 1129 | 0.090 |
Why?
|
Brain Diseases | 2 | 2011 | 1554 | 0.090 |
Why?
|
Telemetry | 1 | 2012 | 200 | 0.090 |
Why?
|
Sleep Stages | 1 | 2014 | 706 | 0.090 |
Why?
|
Ovulation | 1 | 2011 | 181 | 0.090 |
Why?
|
Critical Care | 3 | 2018 | 2715 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2016 | 2538 | 0.080 |
Why?
|
Mental Recall | 1 | 2016 | 1226 | 0.080 |
Why?
|
Speech Perception | 3 | 1991 | 510 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5884 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8542 | 0.080 |
Why?
|
Electrocardiography | 3 | 2015 | 6412 | 0.080 |
Why?
|
Emergency Medical Services | 3 | 2010 | 1947 | 0.080 |
Why?
|
Autonomic Pathways | 1 | 2009 | 31 | 0.080 |
Why?
|
Benzodiazepines | 1 | 2015 | 1138 | 0.080 |
Why?
|
Arousal | 1 | 2015 | 1180 | 0.080 |
Why?
|
Brain Mapping | 3 | 2014 | 6685 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21206 | 0.080 |
Why?
|
Estradiol | 3 | 2011 | 1951 | 0.080 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2009 | 118 | 0.080 |
Why?
|
Phonetics | 2 | 1991 | 204 | 0.070 |
Why?
|
Plastics | 1 | 2008 | 119 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2020 | 1885 | 0.070 |
Why?
|
Checklist | 1 | 2015 | 840 | 0.070 |
Why?
|
Biological Clocks | 1 | 2010 | 321 | 0.070 |
Why?
|
Affect | 1 | 2015 | 1495 | 0.070 |
Why?
|
Internship and Residency | 2 | 2023 | 5953 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1673 | 0.070 |
Why?
|
Biomedical Research | 1 | 2023 | 3463 | 0.070 |
Why?
|
Sudden Infant Death | 1 | 2010 | 293 | 0.070 |
Why?
|
Incidence | 3 | 2017 | 21538 | 0.070 |
Why?
|
Developmental Disabilities | 1 | 2016 | 1518 | 0.070 |
Why?
|
Receptors, Opioid, mu | 1 | 2008 | 171 | 0.070 |
Why?
|
Telencephalon | 1 | 1987 | 143 | 0.070 |
Why?
|
Infant | 3 | 2016 | 36535 | 0.070 |
Why?
|
Ventricular Fibrillation | 1 | 2009 | 537 | 0.070 |
Why?
|
Plant Preparations | 1 | 2007 | 94 | 0.070 |
Why?
|
Speech Disorders | 1 | 1987 | 179 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 709 | 0.070 |
Why?
|
Action Potentials | 1 | 2013 | 1838 | 0.060 |
Why?
|
Electrodes | 1 | 2008 | 617 | 0.060 |
Why?
|
Concept Formation | 1 | 1987 | 160 | 0.060 |
Why?
|
Electric Countershock | 1 | 2009 | 534 | 0.060 |
Why?
|
Corpus Callosum | 1 | 2011 | 753 | 0.060 |
Why?
|
Aromatase Inhibitors | 1 | 2010 | 519 | 0.060 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2008 | 337 | 0.060 |
Why?
|
Craniotomy | 1 | 2010 | 736 | 0.060 |
Why?
|
Aphasia, Wernicke | 3 | 1991 | 19 | 0.060 |
Why?
|
Skull | 1 | 2010 | 820 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2420 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2012 | 958 | 0.060 |
Why?
|
Carbamazepine | 3 | 2016 | 224 | 0.060 |
Why?
|
Benzhydryl Compounds | 1 | 2012 | 944 | 0.060 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2005 | 300 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3109 | 0.060 |
Why?
|
Aphasia, Broca | 3 | 1991 | 52 | 0.060 |
Why?
|
Neural Pathways | 1 | 2016 | 3117 | 0.060 |
Why?
|
Child | 9 | 2019 | 80917 | 0.060 |
Why?
|
Phytotherapy | 1 | 2007 | 298 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 441 | 0.060 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2008 | 542 | 0.060 |
Why?
|
Nitriles | 1 | 2010 | 980 | 0.060 |
Why?
|
Triazoles | 1 | 2010 | 904 | 0.060 |
Why?
|
Morphine | 1 | 2008 | 658 | 0.060 |
Why?
|
Cohort Studies | 9 | 2019 | 41754 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6340 | 0.050 |
Why?
|
Plethysmography | 2 | 2014 | 172 | 0.050 |
Why?
|
Heart Conduction System | 1 | 2009 | 1009 | 0.050 |
Why?
|
Testosterone | 3 | 2010 | 2491 | 0.050 |
Why?
|
Age Distribution | 1 | 2009 | 2873 | 0.050 |
Why?
|
Hypogonadism | 1 | 2010 | 805 | 0.050 |
Why?
|
Boston | 1 | 2016 | 9374 | 0.050 |
Why?
|
Child, Preschool | 3 | 2016 | 42669 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1426 | 0.050 |
Why?
|
Hospitals, Veterans | 1 | 2005 | 395 | 0.050 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 553 | 0.050 |
Why?
|
Meningioma | 1 | 2012 | 1220 | 0.050 |
Why?
|
Language | 1 | 2012 | 1557 | 0.050 |
Why?
|
Meningeal Neoplasms | 1 | 2012 | 1253 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1489 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15454 | 0.050 |
Why?
|
Syncope | 1 | 2005 | 430 | 0.050 |
Why?
|
Cognition | 1 | 2019 | 7073 | 0.050 |
Why?
|
Primary Prevention | 1 | 2009 | 1188 | 0.050 |
Why?
|
Nurses | 1 | 2011 | 2501 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2973 | 0.050 |
Why?
|
Biopsy | 1 | 2013 | 6793 | 0.050 |
Why?
|
Time Factors | 6 | 2017 | 40218 | 0.050 |
Why?
|
Gonadal Steroid Hormones | 1 | 2005 | 707 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15948 | 0.050 |
Why?
|
Steroids | 1 | 2006 | 938 | 0.050 |
Why?
|
Neuropsychological Tests | 5 | 2019 | 7140 | 0.050 |
Why?
|
Maternal Exposure | 1 | 2008 | 1096 | 0.050 |
Why?
|
Cannabis | 1 | 2007 | 446 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 22291 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 1987 | 1485 | 0.040 |
Why?
|
Health Surveys | 1 | 2010 | 4057 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 74944 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20227 | 0.040 |
Why?
|
Pilot Projects | 3 | 2019 | 8741 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1281 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8759 | 0.040 |
Why?
|
Memory Disorders | 2 | 2008 | 1200 | 0.040 |
Why?
|
United States | 5 | 2017 | 73039 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7243 | 0.040 |
Why?
|
Pregnancy | 3 | 2016 | 30256 | 0.040 |
Why?
|
Aging | 2 | 2015 | 8744 | 0.040 |
Why?
|
Double-Blind Method | 4 | 2016 | 12465 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6669 | 0.030 |
Why?
|
Preoperative Care | 1 | 2006 | 2258 | 0.030 |
Why?
|
Speech | 1 | 2022 | 557 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 2001 | 663 | 0.030 |
Why?
|
Meningitis | 1 | 2018 | 219 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2023 | 5315 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13671 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2023 | 939 | 0.030 |
Why?
|
Age Factors | 4 | 2017 | 18412 | 0.030 |
Why?
|
Sex Factors | 2 | 2024 | 10632 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 323 | 0.030 |
Why?
|
Dysphonia | 1 | 2018 | 144 | 0.030 |
Why?
|
Phenytoin | 2 | 2006 | 189 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2479 | 0.030 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 301 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12543 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2000 | 969 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2013 | 36743 | 0.030 |
Why?
|
Reaction Time | 2 | 2019 | 2101 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9514 | 0.030 |
Why?
|
Observation | 1 | 2015 | 310 | 0.030 |
Why?
|
Forecasting | 1 | 2022 | 2945 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1643 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2862 | 0.030 |
Why?
|
Electrodes, Implanted | 2 | 2009 | 836 | 0.030 |
Why?
|
New Zealand | 1 | 2013 | 360 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2359 | 0.030 |
Why?
|
Logistic Models | 1 | 2006 | 13290 | 0.020 |
Why?
|
Anovulation | 1 | 2011 | 54 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1216 | 0.020 |
Why?
|
Paired-Associate Learning | 1 | 1991 | 54 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 26379 | 0.020 |
Why?
|
Israel | 1 | 2013 | 726 | 0.020 |
Why?
|
Attitude to Health | 1 | 2000 | 2025 | 0.020 |
Why?
|
Attention | 2 | 2019 | 2424 | 0.020 |
Why?
|
Oximetry | 1 | 2014 | 462 | 0.020 |
Why?
|
Child Abuse | 1 | 2019 | 1091 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2420 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10760 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 14164 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2000 | 2029 | 0.020 |
Why?
|
Wakefulness | 1 | 2017 | 1284 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2566 | 0.020 |
Why?
|
Australia | 1 | 2013 | 1265 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2000 | 2337 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2107 | 0.020 |
Why?
|
Curriculum | 1 | 2023 | 3782 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2014 | 881 | 0.020 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2008 | 7 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 937 | 0.020 |
Why?
|
Anomia | 1 | 1988 | 13 | 0.020 |
Why?
|
Dyslexia, Acquired | 1 | 1988 | 14 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4423 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 556 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2008 | 205 | 0.020 |
Why?
|
Brain Abscess | 1 | 2008 | 123 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1514 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15869 | 0.020 |
Why?
|
Androstanes | 1 | 2006 | 20 | 0.020 |
Why?
|
Speech Production Measurement | 1 | 1987 | 99 | 0.020 |
Why?
|
Scalp | 1 | 2009 | 391 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3436 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9669 | 0.020 |
Why?
|
Speech Acoustics | 1 | 1987 | 155 | 0.020 |
Why?
|
Confusion | 1 | 2008 | 278 | 0.020 |
Why?
|
Meningitis, Bacterial | 1 | 2008 | 225 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2006 | 455 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2014 | 1448 | 0.020 |
Why?
|
Biological Availability | 1 | 2006 | 389 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 2006 | 259 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3479 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3436 | 0.020 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 193 | 0.010 |
Why?
|
Drug Interactions | 1 | 2009 | 1419 | 0.010 |
Why?
|
Voice | 1 | 1987 | 268 | 0.010 |
Why?
|
Eicosapentaenoic Acid | 1 | 2008 | 565 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2357 | 0.010 |
Why?
|
Auditory Perception | 1 | 2008 | 587 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3620 | 0.010 |
Why?
|
Marijuana Smoking | 1 | 2007 | 261 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 2005 | 822 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14729 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6498 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 20760 | 0.010 |
Why?
|
Cerebral Palsy | 1 | 2007 | 480 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2019 | 4640 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3347 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 2008 | 914 | 0.010 |
Why?
|
Syndrome | 1 | 1987 | 3272 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6316 | 0.010 |
Why?
|
Hypertension | 1 | 2000 | 8616 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8509 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2014 | 4530 | 0.010 |
Why?
|
Prognosis | 1 | 2000 | 30010 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6082 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8054 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2937 | 0.010 |
Why?
|
Critical Illness | 1 | 2010 | 2756 | 0.010 |
Why?
|
Amygdala | 1 | 2005 | 1380 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12421 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17622 | 0.010 |
Why?
|
Brain Injuries | 1 | 2005 | 2057 | 0.010 |
Why?
|
Hippocampus | 1 | 2005 | 3785 | 0.010 |
Why?
|
Registries | 1 | 2008 | 8375 | 0.010 |
Why?
|
Mass Screening | 1 | 2007 | 5458 | 0.010 |
Why?
|
Research Design | 1 | 2007 | 6211 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 13053 | 0.010 |
Why?
|
Brain Damage, Chronic | 1 | 1991 | 265 | 0.010 |
Why?
|